Roles
- Assistant Professor of Clinical Medicine
-
Biography
Dr. Holtzman is an Assistant Professor of Medicine, who joined the University of Miami Division of Transplantation and Cellular Therapy in 2023. Her clinical and research interests focus on improving post-transplant outcomes for patients with acute leukemia and myeloid neoplasms, including development of novel immunomodulatory approaches for relapse prevention and treatment of Graft-versus-Host Disease (GVHD). Dr. Holtzman also sees patients in specialty clinics focused on Geri-Oncology and Chronic GVHD. -
Education & Training
Education
-
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Planting the Seeds of Discovery: ACS Grants Boost Budding Investigators’ Research
Sylvester’s 2024 K12 Scholars
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
To test a drug (pacritinib) in people with moderate or severe cGVHD that has not responded to previous treatment.
- Principal Investigator: Noa Holtzman
- Study Phase: Phase I/II
- Enrollment Status: Open
-
The purpose of this research study is to determine if ruxolitinib (study drug) is more effective than prednisone, the current standard of care, as initial therapy for cGvHD.
- Principal Investigator: Noa Holtzman
- Study Phase: Phase II
- Enrollment Status: Open
